Aujeszky's disease virus: opportunities and challenges | Veterinary Research, a journal on Animal Infection

Free Access

Issue		Vet. Res. Volume 31, Number 1, January-February 2000


Page(s)		121 - 131
DOI		https://doi.org/10.1051/vetres:2000060
How to cite this article		Vet. Res. (2000) 121-131

References

1: Arellano P.E., Morrison R.B., Molitor T.W., Thawley D.G., High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs, J. Am. Vet. Med. Assoc. 200 (1992) 685-691.
2: Baskerville A., Aujeszky's disease: recent advances and current problems, N. Z. Vet. J. 29 (1981) 183-189.
3: Ben-Porat T., DeMarchi J.M., Lomniczi B., Kaplan A.S., Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies, Virology 154 (1986) 325-331.
4: Bouma A., De Jong M.C., Kimman T.G., The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination, Vaccine 15 (1997) 287-294.
5: Bouma A., Zwart R.J., De Bruin M.G., De Jong M.C., Kimman T.G., Bianchi A.T., Immunohistological characterization of the local cellular response directed against pseudorabies virus in pigs, Vet. Microbiol. 58 (1997) 145-151.
6: Brockmeier S.L., Lager K.M., Tartaglia J., Riviere M., Paoletti E., Mengeling W.L.,Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses, Vet. Microbiol. 38 (1993) 41-58.
7: Brockmeier S.L., Lager K.M., Mengeling W.L., Successful pseudorabies vaccination in maternally immune piglets using recombinant vaccinia virus vaccines, Res. Vet. Sci. 62 (1997) 281-287.
8: Brockmeier S.L., Lager K.M., Mengeling W.L., Vaccination with recombinant vaccinia virus vaccines expressing glycoprotein genes of pseudorabies virus in the presence of maternal immunity, Vet. Microbiol. 58 (1997) 93-99.
9: Bullock W.E., Anergy and infection, Adv. Intern. Med. 21 (1976) 149-173.
10: De Bruin M.G., De Visser Y.E., Kimman T.G., Bianchi A.T., Time course of the porcine cellular and humoral immune responses in vivo against pseudorabies virus after inoculation and challenge: significance of in vitro antigenic restimulation, Vet. Immunol. Immunopathol. 65(1998) 75-87.
11: de Leeuw P.W., van Oirschot J.T., Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions, Vet. Q. 7 (1985) 191-197.
12: Donaldson J.T., Wardly R.C., Martin S., Harkness J.W., Influence of vaccination of Aujeszky's disease virus and disease transmission, Vet. Record. 115 (1987) 121-126.
13: Eloit M., Fargeaud D., L'Haridon R., Toma B., Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies, Arch Virol. 99 (1988) 45-51.
14: Firkins L.D., Weigel R.M., Biehl L.G., Hahn E.C., Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E, Am. J. Vet. Res. 58 (1997) 976-984.
15: Gerdts V., Jons A., Makoschey B., Visser N., Mettenleiter T.C., Protection of pigs against Aujeszky's disease by DNA vaccination, J. Gen. Virol. 78 (1997) 2139-2145.
16: Haagmans B.L., van Rooij E.M., Dubelaar M., Kimman T.G., Horzinek M.C., SchijnsV.E., Bianchi A.T., Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D, Vaccine 17 (1999) 1264-1271.
17: Katayama S., Okada N., Yoshiki K., Okabe T., Shimizu Y., Protective effect of glycoprotein gC-rich antigen against pseudorabies virus, J. Vet. Med. Sci. 59 (1997) 657-660.
18: Katayama S., Yoshiki K., Okada N., Kokubu T., Shimizu Y., Efficacy of a mixed glycoprotein vaccine against pseudorabies in pregnant sows. J. Vet. Med. Sci. 60 (1998) 23-28.
19: Kimman T.G., Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies, Vaccine 10 (1992) 363-365.
20: Kimman T.G., De Wind N., De Bruin T., de Visser Y., Voermans J., Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity, Virol. 205 (1994) 511-518.
21: Kimman T.G., De Bruin T.M.G., Voermans J.J.M., Peeters B.P.H., Bianchi A.T.T., Development of antigen specificity of the lymphoproliferation response of pigs to pseudorabies virus: dichotomy between secondary B- and T-cells responses. Immunol. 86 (1995) 372-378.
22: Krieg A.M., Yi A.K., Schorr J., Davis H.L., The role of CpG dinucleotides in 1998 DNA vaccines, Trends Microbiol. 6 (1998) 23-27.
23: Labarque G.G., Nauwynck H.J., Maes D.G., Pensaert M.B., Protection of fattening pigs against challenge with Aujeszky's disease virus after a successive intranasal/intramuscular vaccination., Vet. Q. 21 (1999) 104-107.
24: Le Potier M.F., Monteil M., Houdayer C., Eloit M., Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies. Vet. Microbiol. 55 (1997) 75-80.
25: Lunney J.K., Saalmuller A., Pauly T., Boyd P., Hyatt S., Strom D., Martin S., Zuckermann F.A., Cellular Immune Responses Controlling Infectious Diseases, in: M.E. Tumbleson and L.B. Schook. (Eds.), Advances in Swine in Biomedical Research, Plenum Press, p. 307.
26: Marchioli C.C., Yancey R.J. Jr., Petrovskis E.A., Timmins J.G., Post L.E., Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells, J. Virol. 61 (1987) 3977-3981.
27: Martin S., Wardley R.C., Donaldson A.I., Functional antibody responses in pigs vaccinated with live and inactivated Aujeszky's disease virus, Res. Vet. Sci. 41 (1986) 331-335.
28: Martin S., Russell P.F., Jaqua P.M., Grimm S., Lowery D., Strom D., Zuckermann F.A., Effects of cytokines upon the immune response of swine to Aujeszky's disease virus, 3rd International Symposium on PRRS and Aujeszky's disease, Ploufragan, France, 21-24 June 1999, Vet. Res. 31 (2000) 133-134.
29: Matsuda A., Okada N., Katayama S., Okabe T., Sasaki N., Characterization of protective viral glycoproteins for pseudorabies virus infection, J. Vet. Med. Sci. 53 (1991) 737-741.
30a: McKnight A.J., Zimmer G.J., Fogelman I., Wolf S.F., Abbas A.K., Effects of IL-12 on helper T cell-dependent immune responses in vivo, J. Immunol. 152 (1994) 2172-2181.
30b: Meier W., Wheeler J., Husmann R.J., Osorio F., Zuckermann F.A., Characteristics of the immune response of pigs to PRRS virus, 3rd International Symposium on PRRS and Aujeszky's disease, Ploufragan, France, 21-24 June 1999, Vet. Res. 31 (2000) 41.
31: Mettenleiter T.C. , Molecular biology of pseudorabies (Aujeszky's disease) virus, Comp. Immun. Microbiol. Infect. Dis. 14 (1991) 151-158.
32: Mettenleiter T.C., Immunobiology of pseudorabies (Aujeszky's disease), Vet. Immunol. Immunopathol. 54 (1996) 221-229.
33: Monteil M., Le Potier M.F., Guillotin J., Cariolet R., Houdayer C., Eloit M., Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams, Vet . Res. 27 (1996) 443-452.
34: Monteil M., Le Potier M.F., Cariolet R., Houdayer C., Eloit M., Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth, J. Gen. Virol. 78 (1997) 3303-3310.
35: Nakamura T., Ihara T., Nunoya T., Kuwahara H., Ishihama A., Ueda S., Role of pseudorabies virus glycoprotein II in protection from lethal infection, Vet. Microbiol. 36 (1993) 83-88.
36: Ober B.T., Summerfield A., Mattlinger C., Wiesmuller K.H., Jung G., Pfaff E., Saalmuller A., Rziha H.J., Vaccine-induced, pseudorabies virus-specific, extrathymic CD4⁺CD8⁺ memory T-helper cells in swine, J Virol. 72 (1998) 4866-4870.
37: Riviere M., Tartaglia J., Perkus M.E., Norton E.K., Bongermino C.M., Lacoste F., Duret C., Desmettre P., Paoletti E., Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants, J. Virol. 66 (1992) 3424-3429.
38: Romani L., Puccetti P., Bistoni F., Interleukin-12 in infectious diseases, Clin. Microbiol. Rev. 10 (1997) 611-636.
39: Schang L.M., Kutish G.F., Osorio F.A., Correlation between precolonization of trigeminal ganglia by attenuated strains of pseudorabies virus and resistance to wild-type virus latency, J. Virol. 68 (1994) 8470-8476.
40: Schijns V.E., Haagmans B.L., M.C. Horzinek, IL-12 stimulates an antiviral type-1 cytokine response but lacks adjuvant activity in IFN- $\gamma$ -receptor-deficient mice, J. Immunol. 155 (1995) 2525-2532.
41a: Scott P., Trinchieri G., IL-12 as an adjuvant for cell-mediated immunity, Semin. Immunol. 9 (1997) 285-291.
41b: Somasundaram C., Takamatsu H., Lefèvre F., Charley B., Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus, 3rd International Symposium on PRRS and Aujeszky's disease, Ploufragan, France, 21-24 June 1999, Vet. Res. 31 (2000) 134-135.
42: Stegeman J.A., Kimman T.G., Van Oirschot J.T., Tielen M.J., Hunneman W.A., Spread of Aujeszky's disease virus within pig herds in an intensively vaccinated region, Vet. Rec. 134 (1994) 327-330.
43: Stegeman J.A., Tielen M.J., Kimman T.G., Van Oirschot J.T., Hunneman W.A., Berndsen F.W., Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infections, Vaccine 12 (1994) 527-531.
44: Stegeman A., Van Oirschot J.T., Kimman T.G., Tielen M.J., Hunneman W.A., Berndsen F.W., Reduction of the prevalence of pseudorabies virus-infected breeding pigs by use of intensive regional vaccination, Am. J. Vet. Res. 55 (1994) 1381-1385.
45: Stegeman A., Van Nes A., de Jong M.C., Bolder F.W., Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs. Am.J. Vet. Res. 56 (1995) 573-578.
46: Stellman C., Vannier P., Chappuis G., Brunn A., Dauvergne M., Fargeaud D., Bugand M., Colson X., The potency testing of pseudorabies vaccines in pigs: a proposal for a quantitative criterion and a minimum requirement, J. Biol. Stand. 17 (1989) 17-27.
47: Summerfield A., Rziha H.J., Saalmuller A., Functional characterization of porcine CD4⁺CD8⁺ extrathymic T lymphocytes, Cell Immunol. 168 (1996) 291-298.
48: Trinchieri G., Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity, Annu. Rev. Immunol. 13 (1995) 251-276.
49: Vanderpooten A., Goddeeris B., De Roose P., Hendrickx L., Biront P., Desmettre P., Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs, Vet. Microbiol. 55 (1997) 81-86.
50: Vannier P., Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity, Am. J. Vet. Res. 46 (1985) 1498-1502.
51: Vannier P., Hutet E., Bourgueil E., Cariolet R., Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines, Vet. Microbiol. 29 (1991) 213-223.
52: Van Oirschot J.T., deLeeuw P.W., Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres, Vet. Microbiol. 10 (1985) 401-408.
53: van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A., Stegeman J.A., The use of marker vaccines in eradication of herpesviruses, J. Biotechnol. 44 (1996) 75-81.
54: van Rooij E.M., Haagmans B.L., de Visser Y.E., de Bruin M.G., Boersma W., Bianchi A.T., Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs, Vet. Immunol. Immunopathol. 66 (1998) 113-117.
55: Vilnis A., Sussman M.D., Thacker B.J., Senn M., Maes R.K., Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge, Vet. Microbiol. 62 (1998) 81-96.
56: Wardley R.C., Thomsen D.R., Berlinski P.J., Post L.E., Meyer A.L., Petrovskis E.A., Chester S.T., Immune response in pigs to Aujeszky's disease viruses defective in glycoprotein g1 or gX, Res. Vet. Sci. 50 (1991) 178-183.
57: Wattrang E., Wallgren P., Fuxler L., Lindersson M., Fossum C., Tissue chambers - a useful model for in vivo studies of cytokine production in the pig. Vet. Immunol. Immunopathol. 56 (1997) 133-139.
58: Wittmann G., Spread and control of Aujeszky's disease (AD). Comp. Immunol. Microbiol. Infect. Dis. 14 (1991) 165-173.
59: Zuckermann F.A., Zsak L., Mettenleiter T.C., Ben-Porat T., Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes, J. Virol. 64 (1990) 802-812.
60: Zuckermann F.A., Husmann R.J., Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double-positive T cells. Immunology 87 (1996) 500-509.
61: Zuckermann F.A., Husmann R.J., Schwartz R., Brandt J., Mateu de Antonio E., Martin S., Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine, Vet. Immunol. Immunopathol. 63 (1998) 57-67.
62: Zuckermann F.A., Martin S., Husmann R.J., Brandt J., Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine, Adv. Vet. Med. 41 (1999) 447-461.

Abstract